Comparing CellCept vs Rapamune
CellCept (mycophenolate mofetil) | Rapamune (sirolimus) |
|
---|
CellCept (mycophenolate mofetil) | Rapamune (sirolimus) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Organ Transplant - Rejection Prophylaxis. CellCept may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Lymphangioleiomyomatosis, Organ Transplant - Rejection Prophylaxis. Rapamune may also be used for purposes not listed in this medication guide. |
Related suggestions Organ Transplant, Rejection Prophylaxis
|
|||||||
More about CellCept (mycophenolate mofetil) | More about Rapamune (sirolimus) | ||||||||
Ratings & Reviews | |||||||||
CellCept has an average rating of 8.3 out of 10 from a total of 35 ratings on Drugs.com. 77% of reviewers reported a positive effect, while 6% reported a negative effect. |
Rapamune has an average rating of 7.0 out of 10 from a total of 3 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all CellCept side effects |
View all Rapamune side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all CellCept prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
Other mycophenolate mofetil brands include: Myhibbin |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
18 hours |
78 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 351 drugs are known to interact with CellCept:
|
A total of 726 drugs are known to interact with Rapamune:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
May 03, 1995 |
September 15, 1999 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Prograf
Prograf is used to prevent your body from rejecting a heart, liver, or kidney transplant. Learn ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Envarsus XR
Envarsus XR is used for organ transplant, rejection prophylaxis
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Sirolimus
Sirolimus (Rapamune) is a prescription medicine used to prevent organ rejection after a kidney ...
Everolimus
Everolimus (Afinitor, Afinitor Disperz, Zortress) belongs to a class of drugs called kinase ...
Cyclophosphamide
Cyclophosphamide is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, brain ...
Cyclosporine
Cyclosporine is used for cogan's syndrome, crohn's disease, eczema, evan's syndrome, focal ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.